Panama7 Shares of Sanofi (NASDAQ:SNY) have yet to fully recover from the business strategy change the company dropped on investors in October 2023. At the time, Sanofi announced plans to increase R&D investments to “drive long-term growth and enhance shareholder value” and to separate its consumer healthcare business to enable greater focus and resources to the biopharma business. This was a shocking turn of events for a slow-growing, dividend-paying company, and I understand the reluctance of the sharehold ...